An overdose death involving the insufflation of extended-release oxymorphone tablets

Journal of Analytical Toxicology

Volumn 34, Issue 8, 2010, Pages 521-526

  Vorce, Shawn P ^a   Levine, Barry ^a   McDonough, Pamela C ^a   Past, Marilyn R ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYALPRAZOLAM; ALPHA HYDROXYALPRAZOLAM TERT BUTYLDIMETHYLSILYL DERIVATIVE; ALPRAZOLAM; DEXTROMETHORPHAN; DOXYLAMINE; DRUG METABOLITE; OXAZEPAM; OXIME OXYMORPHONE TRIMETHYLSILYL DERIVATIVE; OXYMORPHONE; TEMAZEPAM; TRIMETHYLSILYL DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AERATION; ARTICLE; CASE REPORT; CATALEPSY; CAUSE OF DEATH; CONTROLLED STUDY; CYANOSIS; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FATALITY; DRUG ISOLATION; DRUG OVERDOSE; DRUG RELEASE; DRUG URINE LEVEL; FEMALE; HUMAN; LIMIT OF QUANTITATION; MASS FRAGMENTOGRAPHY; QUANTITATIVE ANALYSIS; RESUSCITATION; STOMACH CONTENT; UNCONSCIOUSNESS; URINALYSIS;

EID: 79954620608     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/34.8.521     Document Type: Article

References (12)

1. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 7th ed. Biomedical Publications Foster City, CA, 2004, pp 833-834.
2. Opana® monograph. Endo Pharmaceuticals, Inc., 2008.
3. Physicians' Desk Reference, OPANA® ER CII Rx Tablet, Extended-Release (oxymorphone hydrochloride): Endo Pharmaceuticals, PDR Electronic Library, Version 7.0.324b-2009.3.0. Thomson PDR, Montvale, NJ, 2009.
4. P. Sloan. Review of oral oxymorphone in the management of pain. Ther. Clin. Risk Manag. 4(4): 777-787 (2008).
5. H.S. Smith. Clinical pharmacology of oxymorphone. Pain Med. 10: S3-S10 (2009).
6. M.A. Hussain and B.J. Aungst. Intranasal absorption of oxymorphone. J. Pharm. Sci. 86(8): 975-976 (1997).
7. J.M. White and R.J. Irvine. Mechanisms of fatal opioid overdose. Addiction 94(7): 961-972 (1999).
8. D. Garside, R.L. Hargrove, and R.E. Winecker. Concentration of oxymorphone in postmortem fluids and tissue. J. Anal. Toxicol. 33: 121-128 (2009).
9. R. Meatherall. GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood. J. Anal. Toxicol. 29: 301-308 (2005).
10. J.D. Ropero-Miller, M.K. Lambing, and R.E. Winecker. Simultaneous quantitation of opioids in blood by GC-EI-MS analysis following deproteination, detautomerization of keto analytes, solid-phase extraction, and trimethylsilyl derivatization. J. Anal. Toxicol. 26: 524-528 (2002).
11. M. Cremese, A.H.B. Wu, G. Cassella, E. O'Connor, K. Rymut, and D.W. Hill. Improved GC/MS analysis of opiates with use of oxime-TMS derivatives. J. Forensic Sci. 43: 1220-1224 (1998).
12. G.K. Isbister, L. O'Regan, D. Sibbritt, and I.M. Whyte. Alprazolam is relatively more toxic than other benzodiazepines in overdose. Br. J. Clin. Pharmacol. 58(1): 88-95 (2004).